Heterosexual AIDS Cases Up Sharply, But Numbers Remain Small

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 1
Volume 4
Issue 1

BETHESDA, Md--As expected, the number of reported AIDS cases increased substantially in 1993 due to the expansion of the surveillance case definition in January of that year, but an adjusted analysis shows only a slight overall increase.

BETHESDA, Md--As expected, the number of reported AIDS cases increasedsubstantially in 1993 due to the expansion of the surveillancecase definition in January of that year, but an adjusted analysisshows only a slight overall increase.

This analysis showed a 1993 incidence increase of 3% (62,000 casesin 1993 versus 60,000 in 1992). However, a slight decrease (1%)was seen in homosexual/bisexual men, while the AIDS incidencefor intravenous drug users increased by 8%, and for heterosexualsby 23% (MMWR 43:826-831, 1994).

Still, the number of persons infected through heterosexual contactremains small (7,500 in 1993), compared with the number infectedthrough homosexual sex (30,300) or IV drug use (17,800).

The report also showed significant geographic differences in AIDSincidence trends. Although the number of cases contracted throughheterosexual sex rose in all four regions of the country, theincreases varied widely, from 11% in the South to 39% in the Northeast.

The incidence among IV drug users increased in the Northeast,where most lived when diagnosed, but remained stable in the Southand West. The number of homosexual cases decreased in the Westwhile remaining stable in the Northeast, South, and Midwest.

Recent Videos
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
4 experts are featured in this series.
4 experts are featured in this series.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
Two experts are featured in this series.
Related Content